Search research articles
Contact Us
Filters
Showing results (231-240 of 347) with videos related to
Page
of 35
Sort By:
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
October 21, 2014
[A standard protocol for detection of EGFR mutations in cytologic specimens]
Zheng Wang, Xiaonan Wu, Yuankai Shi, et al.
British Journal of Cancer
|
February 14, 2018
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)
Baohui Han, Kai Li, Yizhuo Zhao, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
April 19, 2019
Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China
Yuankai Shi, Ying Han, Jianliang Yang, et al.
Cancer Immunology, Immunotherapy : CII
|
October 2, 2024
Multi-omics analysis and response prediction of PD-1 monoclonal antibody containing regimens in patients with relapsed/refractory diffuse large B-cell lymphoma
Xinrui Chen, Yan Qin, Xuemin Xue, et al.
The Journal of Molecular Diagnostics : JMD
|
November 22, 2016
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma
Zheng Wang, Gang Cheng, Xiaohong Han, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
January 28, 2016
[A standardized protocol for detection of ALK protein expression and gene fusion in lung adenocarcinoma cytologic specimens]
Zheng Wang, Xiaonan Wu, Yuankai Shi, et al.
Cancer Medicine
|
March 20, 2016
A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patients
Hongnan Mo, Xuezhi Hao, Yutao Liu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
January 13, 2025
Efficacy, safety, and multi-omics analysis of pembrolizumab combined with nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: A single-arm phase 2 study
Lin Gui, Xinrui Chen, Wen Zhang, et al.
Chronic Diseases and Translational Medicine
|
September 10, 2021
Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study
Hongnan Mo, Peng Liu, Yan Qin, et al.
Asia-Pacific Journal of Clinical Oncology
|
January 20, 2017
Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicity
Youwu Shi, Peng Liu, Shengyu Zhou, et al.
Page
of 35
Search research articles
Search
Showing results (231-240 of 347) with videos related to
Sort By:
Page
of 35
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
October 21, 2014
[A standard protocol for detection of EGFR mutations in cytologic specimens]
Zheng Wang, Xiaonan Wu, Yuankai Shi, et al.
British Journal of Cancer
|
February 14, 2018
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)
Baohui Han, Kai Li, Yizhuo Zhao, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
April 19, 2019
Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China
Yuankai Shi, Ying Han, Jianliang Yang, et al.
Cancer Immunology, Immunotherapy : CII
|
October 2, 2024
Multi-omics analysis and response prediction of PD-1 monoclonal antibody containing regimens in patients with relapsed/refractory diffuse large B-cell lymphoma
Xinrui Chen, Yan Qin, Xuemin Xue, et al.
The Journal of Molecular Diagnostics : JMD
|
November 22, 2016
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma
Zheng Wang, Gang Cheng, Xiaohong Han, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
January 28, 2016
[A standardized protocol for detection of ALK protein expression and gene fusion in lung adenocarcinoma cytologic specimens]
Zheng Wang, Xiaonan Wu, Yuankai Shi, et al.
Cancer Medicine
|
March 20, 2016
A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patients
Hongnan Mo, Xuezhi Hao, Yutao Liu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
January 13, 2025
Efficacy, safety, and multi-omics analysis of pembrolizumab combined with nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: A single-arm phase 2 study
Lin Gui, Xinrui Chen, Wen Zhang, et al.
Chronic Diseases and Translational Medicine
|
September 10, 2021
Recombinant human thrombopoietin prior to mobilization chemotherapy facilitates platelet recovery in autologous transplantation in patients with lymphoma: Results of a prospective randomized study
Hongnan Mo, Peng Liu, Yan Qin, et al.
Asia-Pacific Journal of Clinical Oncology
|
January 20, 2017
Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicity
Youwu Shi, Peng Liu, Shengyu Zhou, et al.
Page
of 35